Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo

Peptide encyclopedia · Metabolic pathway research

SS-31 research summary

Mitochondria-targeting tetrapeptide · Full compound profile

Also see the expanded SS-31 compound database page with filters, related articles, and catalog links.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.

SS-31 is a mitochondria-targeting tetrapeptide of the sequence D-Arg-Dmt-Lys-Phe-NH2, also developed as elamipretide, MTP-131 and Bendavia. VaultLabs supplies it as a 10 mg lyophilised reference material for in vitro bioenergetics and membrane-interaction research. It is not a medicine and is not for human or veterinary use. In the VaultLabs catalogue this is Mitochondria-targeting tetrapeptide material for in vitro laboratory research, not a medicine and not a protocol.

What it is
Mitochondria-targeting tetrapeptide
Category
Metabolic pathway research
CAS
736992-21-5
Formula
C32H49N9O5
Catalogue price before VAT
10 mg at AED 399

Identity on this record

Chemical name: SS-31 (elamipretide).

Common synonyms: Elamipretide, MTP-131, Bendavia, mitochondria-targeting tetrapeptide.

Sequence: D-Arg-Dmt-Lys-Phe-NH2.

CAS number: 736992-21-5 (registry entry).

Molecular formula: C32H49N9O5.

Molecular weight: 639.79 g/mol.

Appearance: White lyophilised powder.

Catalog strength: 10 mg vial.

Those identifiers describe SS-31 as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.

What the catalogue actually sells

SS-31 10mg is the 10 mg lyophilized unit, listed at AED 399 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.

Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for SS-31, not a delivered-cost quote.

Lots and certificates

Lot VL-SS31-20260917 is the catalogue certificate for SS-31 10mg. Read it on SS-31 10mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

How the compound record describes the literature

SS-31 / elamipretide appears in biophysical and mitochondrial-proteomics literature. A pharmaceutical development programme exists separately. VaultLabs supplies research-grade powder only.

Topics named on the SS-31 record, as literature context rather than as outcomes VaultLabs claims: Mitochondrial membrane-interaction assays; Cardiolipin and bilayer model systems; Non-canonical residue (Dmt) analytical methods.

That is context for identifying SS-31. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Points the monograph already states

Points already written on the SS-31 monograph, so a reader can check them against that page:

Sequence is D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2′,6′-dimethyltyrosine and the C-terminus is amidated.

CAS registry number 736992-21-5; molecular formula C32H49N9O5; molecular weight 639.79 g/mol.

Common research synonyms are elamipretide, MTP-131 and Bendavia — one sequence, several development names.

Published mechanism work describes binding to lipid bilayers and a mitochondrial protein-interaction landscape, not a catalog use instruction.

Catalog presentation is a 10 mg lyophilised vial (VL-SS31-10) with lot-linked HPLC documentation.

Not an approved medicine in the UAE. VaultLabs does not supply it for human administration.

Dispatch and the research-use boundary

VaultLabs dispatches SS-31 from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

The full narrative record is the SS-31 compound monograph. Handling of the sealed unit is the SS-31 storage guide. Questions are collected on the SS-31 FAQ. How it differs from neighbouring records is the SS-31 comparison.

Questions this page answers

What is SS-31 on this site?

SS-31 is a mitochondria-targeting tetrapeptide of the sequence D-Arg-Dmt-Lys-Phe-NH2, also developed as elamipretide, MTP-131 and Bendavia. VaultLabs supplies it as a 10 mg lyophilised reference material for in vitro bioenergetics and membrane-interaction research. It is not a medicine and is not for human or veterinary use. VaultLabs supplies it as in vitro research material. The monograph prints CAS 736992-21-5.

Related compounds

Related articles

Research tools

Catalog products

Next recommended reading

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.